A client with blood type AB negative delivers a newborn with blood type A positive. The cord blood reveals a positive indirect Coombs' test. What is the implication of this finding?
The newborn is infected with an infectious blood-borne disease.
The mother no longer needs Rho (D) immune globulin injections.
The mother's Rh antibodies are present in the neonatal serum.
The newborn needs phototherapy for physiologic jaundice.
The Correct Answer is C
A positive indirect Coombs' test indicates that the mother has developed Rh antibodies against the baby's Rh-positive blood. This finding can result in hemolytic disease of the newborn, which is a condition in which the mother's Rh antibodies atack the baby's red blood cells, causing destruction and potential anemia.
The baby may require phototherapy for physiologic jaundice, but the Coombs' test result indicates a different issue.
The presence of an infectious blood-borne disease cannot be determined from this test.
The mother may still need Rho (D) immune globulin injections after delivery of an Rh-positive baby.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is C
Explanation
Phyto menadione injectable, also known as vitamin K1, is commonly given to newborns to prevent hemorrhagic disease of the newborn (HDN), a bleeding disorder that can occur due to vitamin K deficiency in the first few days of life. Vitamin K is important for the production of clotting factors in the liver, and newborns are at risk of vitamin K deficiency because it does not cross the placenta well and their intestinal flora is not yet established. The other options do not accurately describe the purpose of administering Phyto menadione injectable to newborns.
Correct Answer is A
Explanation
The screening test that should be scheduled for a client who is gravida 4 para 3 at 16-weeks gestation is **Maternal serum alpha-feto protein (MSAFP)**. Second trimester prenatal screening may include several blood tests, called multiple markers. These markers provide information about a woman's risk of having a baby with certain genetic conditions or birth defects. Screening is usually done by taking a sample of the mother's blood between the 15th and 20th weeks of pregnancy (16th to 18th is ideal)².
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.